MCP1 is primarily known to be involved in the recruitment of NK cells to tumors as an inflammatory mediator [57], but more recently, the tumor expression of MCP1 can inhibit the function of NK cells against tumors [58]. This evidence concerns the gene CCL2 and neoplasm.